Silexion Therapeutics Corp (SLXNW) › Cash & EquivalentsSilexion Therapeutics Corp (SLXNW) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $4.59M2024: $1.19M2025: $5.99M$5.99M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$5.99M+404.7%2024$1.19M-74.2%2023$4.59M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share